Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Europe EU Parliament to discuss report on non-communicable diseases this week…
  • Greece Parliament approves tax bill for nic pouches and herbal heated products…
  • Europe EC confirms smoke-free environment recommendation to be adopted in 2024…
  • Luxembourg Health ministry clarifies status of herbal heated products…
  • Bulgaria Tax amendment passes final reading and waits for president’s signatureR ...
  • Ukraine Government to submit a bill relating to tax changes…
  • Serbia Health minister wants stricter public usage rules for smoking…
  • Bahrain Final stage of HTP digital stamp system to be implemented…
  • Ireland Tobacco and nicotine products bill is adopted…
  • United States Menthol cigarette proposed rule review to continue into 2024…
  • Brazil Dates released for consultation of resolution banning heated tobacco…
  • Azerbaijan National Assembly approves tax amendment in third reading…
View all
News analysis

US FDA grants modified risk orders to PMI’s Iqos and Marlboro HeatSticks

Written by || 7th July 2020 || News analysis | Heated tobacco | IQOS | North America United States

The US Food and Drug Administration (FDA) has granted Philip Morris International (PMI) modified risk tobacco product (MRTP) status for Iqos and its associated HeatSticks ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents

Italian health ministry says IQOS ‘reduced-risk’ claim is unproven
PMI lowers expectation of IQOS uptake by half as lockdown hits Heets sales
FDA gives the green light for IQOS roll-out onto the US market

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy. 

    © 2023 Tamarind Media Limited (T/A TobaccoIntelligence)

    TobaccoIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of TobaccoIntelligence, does not accept any liability or responsibility for information or views published.